These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 37078954)
21. A novel BRCA1 duplication and new insights on the spectrum and frequency of germline large genomic rearrangements in BRCA1/BRCA2. Sahin I; Saat H Mol Biol Rep; 2021 Jun; 48(6):5057-5062. PubMed ID: 34146199 [TBL] [Abstract][Full Text] [Related]
22. Homologous recombination in lung cancer, germline and somatic mutations, clinical and phenotype characterization. Kadouri L; Rottenberg Y; Zick A; Hamburger T; Lipson D; Peretz T; Nechushtan H Lung Cancer; 2019 Nov; 137():48-51. PubMed ID: 31542568 [TBL] [Abstract][Full Text] [Related]
23. Dramatic response of FOLFIRINOX regimen in a collision pancreatic adenocarcinoma patient with a germline BRCA2 mutation: a case report. Shimmura H; Kuramochi H; Jibiki N; Katagiri S; Nishino T; Araida T Jpn J Clin Oncol; 2019 Dec; 49(11):1049-1054. PubMed ID: 31612916 [TBL] [Abstract][Full Text] [Related]
24. High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients. Alhuqail AJ; Alzahrani A; Almubarak H; Al-Qadheeb S; Alghofaili L; Almoghrabi N; Alhussaini H; Park BH; Colak D; Karakas B Breast Cancer Res Treat; 2018 Apr; 168(3):695-702. PubMed ID: 29297111 [TBL] [Abstract][Full Text] [Related]
25. Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients. Zhang Y; Wu H; Yu Z; Li L; Zhang J; Liang X; Huang Q BMC Cancer; 2022 Aug; 22(1):842. PubMed ID: 35918668 [TBL] [Abstract][Full Text] [Related]
26. Effectiveness of Neoadjuvant Therapy with Platinum-Based Agents for Patients with BRCA1 and BRCA2 Germline Mutations - A Retrospective Analysis of Breast Cancer Patients Treated at MMCI Brno. Holánek M; Bílek O; Nenutil R; Kazda T; Selingerová I; Zvaríková M; Palácová M; Krásenská M; Vyzula R; Petráková K Klin Onkol; 2019; 32(Supplementum2):31-35. PubMed ID: 31409079 [TBL] [Abstract][Full Text] [Related]
28. Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers. Song Y; Barry WT; Seah DS; Tung NM; Garber JE; Lin NU Cancer; 2020 Jan; 126(2):271-280. PubMed ID: 31581314 [TBL] [Abstract][Full Text] [Related]
32. Complete Response to Chemotherapy in Metastatic Pancreatic Carcinoma Associated with Double Heterozygous Germline Mutation in BRCA2 and CHEK2 Genes - a Case Report. Pazderová N; Urbán V; Makovník M; Macák D; Janega P; Chovanec M; Rejleková K; Mardiak J; Mego M Klin Onkol; 2020; 33(3):220-225. PubMed ID: 32683879 [TBL] [Abstract][Full Text] [Related]
33. Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients. Kim YC; Zhao L; Zhang H; Huang Y; Cui J; Xiao F; Downs B; Wang SM Oncotarget; 2016 Feb; 7(8):9600-12. PubMed ID: 26848529 [TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil. Carraro DM; Koike Folgueira MA; Garcia Lisboa BC; Ribeiro Olivieri EH; Vitorino Krepischi AC; de Carvalho AF; de Carvalho Mota LD; Puga RD; do Socorro Maciel M; Michelli RA; de Lyra EC; Grosso SH; Soares FA; Achatz MI; Brentani H; Moreira-Filho CA; Brentani MM PLoS One; 2013; 8(3):e57581. PubMed ID: 23469205 [TBL] [Abstract][Full Text] [Related]
35. Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series. Sukumar J; Kassem M; Agnese D; Pilarski R; Ramaswamy B; Sweet K; Sardesai S Breast Cancer Res Treat; 2021 Apr; 186(2):569-575. PubMed ID: 33507482 [TBL] [Abstract][Full Text] [Related]
36. Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis. Poveda A; Lheureux S; Colombo N; Cibula D; Lindemann K; Weberpals J; Bjurberg M; Oaknin A; Sikorska M; González-Martín A; Madry R; Pérez MJR; Ledermann J; Davidson R; Blakeley C; Bennett J; Barnicle A; Škof E Gynecol Oncol; 2022 Mar; 164(3):498-504. PubMed ID: 35063276 [TBL] [Abstract][Full Text] [Related]
37. Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer. Chao A; Chang TC; Lapke N; Jung SM; Chi P; Chen CH; Yang LY; Lin CT; Huang HJ; Chou HH; Liou JD; Chen SJ; Wang TH; Lai CH Oncotarget; 2016 Dec; 7(51):85529-85541. PubMed ID: 27907908 [TBL] [Abstract][Full Text] [Related]